Related Experiment Video
Updated: Feb 23, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
PICK1 facilitates lasting reduction in GluA2 concentration in the hippocampus during chronic epilepsy
Jan-Øyvind Lorgen1, Daniel Lawer Egbenya1, Janniche Hammer2
1Division of Anatomy, Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Abstract:
Overstimulation of glutamate receptors resulting in excessive intracellular calcium concentrations is a major cause of neuronal cell death in epilepsy. The main source of increased calcium concentration during this excitotoxicity is an influx through NMDA subtype of glutamate receptors. The GluR2 (GluA2) hypothesis states that following a neurological insult such as an epileptic seizure, the AMPA receptor subunit GluR2 protein is downregulated. This increases the likelihood of the formation of GluR2-lacking, calcium-permeable AMPA receptor which might further enhance the toxicity of the neurotransmitter, glutamate. The cytosolic protein, PICK1, facilitates the removal of GluA2 subunits from the synaptic plasma membrane. High calcium concentrations may cause PICK1 to bind to the GluA2 subunit of calcium-impermeable AMPARs, leading to an increased internalization of these receptor subunits and a relative increase of GluA2-lacking, calcium-permeable AMPARs. This further escalates the cytosolic calcium concentration. In order to test this hypothesis, we have used kainic acid to induce epilepsy in rats. Using semi-quantitative western blotting combined with univariate and multivariate statistical analyses, we found that both GluA2 and PICK1 were down-regulated in kainate-treated rats for as long as eight weeks after induction of epilepsy. An interesting finding was that statistical analysis indicates that the functional role of PICK1 in our material is to increase GluA2 concentrations in the cells. The observed reduction in PICK1 concentration may thus be an independent contributor to the observed GluA2 reduction. This reduction may possibly be an adaptive mechanism, serving to prevent further loss of GluA2 from the synapses.
Insights
In epilepsy, reduced GluR2 (GluA2) and PICK1 proteins may protect neurons from excitotoxicity. This study found lower levels of these proteins in rats after induced seizures, potentially preventing further neuronal damage.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Excitotoxicity, driven by glutamate receptor overstimulation and calcium influx, causes neuronal death in epilepsy.
- The GluR2 (GluA2) hypothesis proposes that reduced GluA2 in AMPA receptors increases calcium permeability, exacerbating excitotoxicity.
- PICK1 protein regulates GluA2 removal from synapses, and its interaction with GluA2 is calcium-dependent.
Purpose of the Study:
- To investigate the GluR2 hypothesis in an epilepsy model.
- To examine the expression levels of GluA2 and PICK1 following kainic acid-induced seizures in rats.
- To determine the relationship between PICK1 and GluA2 in the context of epilepsy.
Main Methods:
- Kainic acid was used to induce epilepsy in a rat model.
- Semi-quantitative western blotting was employed to measure protein levels.
- Univariate and multivariate statistical analyses were performed to assess the data.
Main Results:
- Both GluA2 and PICK1 protein levels were found to be down-regulated in rats for up to eight weeks after epilepsy induction.
- Statistical analysis suggested that PICK1 normally functions to increase GluA2 levels.
- The reduction in PICK1 may contribute to the observed decrease in GluA2.
Conclusions:
- The down-regulation of GluA2 and PICK1 in this epilepsy model may be an adaptive response to limit excitotoxicity.
- Reduced PICK1 could independently contribute to lower GluA2 levels, potentially protecting synapses.
- Further research is needed to fully elucidate the adaptive roles of these proteins in epilepsy.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Long-term Potentiation

